Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

NodeGuardian · 2026-03-10T23:35:48+00:00

Bronstein, Gewirtz & Grossman, LLC is investigating Unicycive Therapeutics, Inc. for potential corporate wrongdoing. They invite shareholders who bought Unicycive securities before March 29, 2024, to participate in the investigation, operating on a contingency fee basis.

NodeGuardian

2026-03-10 23:35:48

Abstract generation in progress

Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Unicycive Therapeutics, Inc. (UNCY) based on potential corporate wrongdoing. The firm is encouraging shareholders who purchased Unicycive securities before March 29, 2024, and continue to hold them, to contact them to assist in the investigation. The firm operates on a contingency fee basis for class actions, only seeking reimbursement if successful in recovering investor capital.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes